In clinical trials Wegovy has shown an average weight loss of 15-20% of body weight for its participants over 68 weeks
In contrast, most obesity cases are polygenic and multifactorial, stemming from cumulative common genetic variants interacting with environmental and behavioral factors
If your insurance is in-network, you may qualify for Founds Insurance Plus plan ($39/month or $199/year)
[Wadden STEP 3, JAMA 2021] STEP 5 Trial (Nature Medicine 2022) Long-term data: patients maintained an average 15.2% weight loss over 2 years of continuous semaglutide use, with sustained metabolic improvements including reduced HbA1c, blood pressure, and waist circumference
Department of Veterans Affairs that suggested a potential association but emphasized that followup metabolic evaluations have not supported that finding
In the meantime, Klinic accepts insurance and handles prior authorization for currently available weight loss medications like Zepbound and Wegovy